article thumbnail

Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance

Journal of the American Heart Association

BackgroundFontan circulation (FC) in complex congenital heart disease is characterized by altered hemodynamics and associated with Fontanassociated liver disease. Journal of the American Heart Association, Ahead of Print. Patients with FC may exhibit abnormalities in cholate clearance due to abnormal perfusion.

article thumbnail

Circulation: Cardiovascular Imaging’s Top 10 Reviewers of 2022-2023

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e016453, January 1, 2024.

article thumbnail

Winning the Battle Against Atherosclerosis: Practical, Proactive Solutions

Cardiometabolic Health Congress

Studies, such as those published in JACC (2022) , show that early identification can lead to targeted interventions, reducing long-term risk. A 2022 study published in Circulation demonstrated that earlier LDL-C reduction leads to compounded cardiovascular benefits over time.

article thumbnail

Growth of Multimodality Cardiac Imagers in the United States, 2013–2022

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print.

article thumbnail

Temporal Trends in Noninvasive and Invasive Cardiac Testing From 2010 to 2022 in the US Medicare Population

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print. in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% to 12.9%.

article thumbnail

Abstract 4119868: Statin and PCSK9 Inhibitor Utilization and Spending in Medicaid between 2018 to 2022: A National Analysis

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4119868-A4119868, November 12, 2024. We evaluated annual trends in utilization (prescription fills) and total spending for statins and PCSK9i from 2018 to 2022, both overall and by individual drug formulation. million in 2022, representing a 0.4% million to $226.8 million to $65.7

article thumbnail

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

Circulation, Ahead of Print.